These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9370949)

  • 21. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
    Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
    Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value.
    Feakins RM; Ghaffar AH
    Hum Pathol; 2003 Apr; 34(4):385-90. PubMed ID: 12733121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin is highly expressed in pancreatic endocrine tumours but not in solid pseudopapillary tumours.
    Mourra N; Couvelard A; Tiret E; Olschwang S; Flejou JF
    Histopathology; 2007 Feb; 50(3):331-7. PubMed ID: 17257128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premetastatic uveal melanoma cells do not express laminin receptors.
    Rohrbach JM; Wild M; Riedinger C; Kreissig I; Thiel HJ
    Ger J Ophthalmol; 1994 May; 3(3):144-7. PubMed ID: 8038682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
    Shyr YM; Su CH; Li AF; Wu CW; Lui WY
    Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic neuroendocrine tumours.
    O'Grady HL; Conlon KC
    Eur J Surg Oncol; 2008 Mar; 34(3):324-32. PubMed ID: 17967523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
    Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
    J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
    Zhang Y; Dang C; Ma Q; Shimahara Y
    Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
    Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
    J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-expression of ghrelin and its receptor in pancreatic endocrine tumours.
    Ekeblad S; Lejonklou MH; Grimfjärd P; Johansson T; Eriksson B; Grimelius L; Stridsberg M; Stålberg P; Skogseid B
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):115-22. PubMed ID: 17201810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
    Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
    Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the metastasis-associated 67 kD laminin receptor.
    Ménard S; Castronovo V; Tagliabue E; Sobel ME
    J Cell Biochem; 1997 Nov; 67(2):155-65. PubMed ID: 9328821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
    Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
    Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.